{"data_non_statistical":false,"goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","graph_title":"\ubc31\uc2e0 \uc811\uc885 \ubaa9\ud45c \uc778\uad6c \ube44\uc728","graph_type":"line","indicator_name":"\uad6d\uac00 \uc815\ucc45\uc5d0 \ud3ec\ud568\ub41c \ubaa8\ub4e0 \ubc31\uc2e0\uc744 \uc811\uc885\ud55c \uc778\uad6c\uc758 \ube44\uc728","indicator_sort_order":"03-0b-01","published":true,"reporting_status":"complete","target_name":"\uac1c\ub3c4\uad6d\uc5d0\uc11c \uc8fc\ub85c \ubc1c\uc0dd\ud558\ub294 \uc804\uc5fc\uc131 \ubc0f \ube44\uc804\uc5fc\uc131 \uc9c8\ubcd1\uc5d0 \ub300\ud55c \ubc31\uc2e0 \ubc0f \uc57d\ud488 \uac1c\ubc1c\uacfc \uc5f0\uad6c \uc9c0\uc6d0, \uc800\ub834\ud55c \uac00\uaca9\uc758 \ud544\uc218 \uc758\uc57d\ud488 \ubc0f \ubc31\uc2e0\uc758 \uc81c\uacf5, \ud2b9\ud788 \ubaa8\ub450\uc5d0\uac8c \uc758\uc57d\ud488\uc5d0 \ub300\ud55c \uc811\uadfc\uc744 \ubcf4\uc7a5","un_custodian_agency":"WHO, UNICEF","page_content":"","en":{"indicator":"3.b.1","layout":"indicator","permalink":"/3-b-1/","sdg_goal":"3","target_id":"3.b","published":true,"target":"Support the research and development of vaccines and medicines for the communicable and non\u2011communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","title":"Proportion of the target population covered by all vaccines included in their national programme","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","national_indicator_description":"Coverage of DTP containing vaccine (3rd dose): Percentage of surviving infants who received the 3 doses  of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year. Coverage of Measles containing vaccine (2nd dose): Percentage of children who received two dose  of measles containing vaccine according to nationally recommended schedule through routine immunization services  in a given year. -Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants  who received the nationally recommended doses of pneumococcal conjugate vaccine in a given year.  -Coverage of HPV vaccine (last dose in the schedule): Percentage of 15 years old girls received  the recommended doses of HPV vaccine. Currently performance of the programme in the previous calendar year based  on target age group is used.","un_designated_tier":"I","un_custodian_agency":"World Health Organization (WHO),  United Nations International Children's Emergency Fund (UNICEF)","national_metadata":"","global_metadata":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","global_metadata_text":"United Nations Sustainable Development Goals Metadata (PDF 4.0 MB)","national_geographical_coverage":"Republic of Korea","computation_units":"Percentage (%)","reporting_status":"complete","data_non_statistical":false,"graph_type":"line","graph_title":"Proportion of the target population with access to Vaccine","data_show_map":false,"source_active_1":false,"source_organisation_1":"National Health Service (NHS) Digital","source_periodicity_1":"Annual","source_earliest_available_1":"2007","source_geographical_coverage_1":"Republic of Korea","source_url_1":"https://digital.nhs.uk/search?q=vaccinations&p=1&mv1=488","source_url_text_1":"Childhood Vaccination Coverage Statistics","source_release_date_1":"18/09/2018","source_next_release_1":"TBC","source_statistical_classification_1":"National Statistic","source_contact_1":"enquiries@nhsdigital.nhs.uk.","source_active_2":false,"source_organisation_2":"Public Health England (PHE)","source_periodicity_2":"Annual","source_earliest_available_2":"2008","source_geographical_coverage_2":"Republic of Korea","source_url_2":"https://www.gov.uk/government/collections/vaccine-uptake#hpv-vaccine-uptake (Data sourced from e-mail correspondance)","source_url_text_2":"Annual UK HPV vaccine coverage data by birth cohort, academic year, dose and country","source_release_date_2":"30/09/2013","source_next_release_2":"TBC","source_statistical_classification_2":"Official Statistic","source_contact_2":"Elise.Tessier@phe.gov.uk","source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"indicator_sort_order":"03-bb-01","source_url_3":"Link to source","source_url_text_4":"Link to source","source_url_text_5":"Link to source","source_url_text_6":"Link to source","source_active_7":false,"source_url_text_7":"Link to source","source_active_8":false,"source_url_text_8":"Link to source","source_active_9":false,"source_url_text_9":"Link to source","page_content":"\u25b6 Data type: Estimated data by international organizations (Type2) This is Korean data prepared by international organizations through estimation and modeling. If there are no national data corresponding to UN SDGs indicators, international data are available for monitoring.\n"},"indicator":"3.b.1","target_id":"3.b","sdg_goal":"3"}